Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells.

[1]  Qin M. Chen,et al.  Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways. , 2008, Toxicology and applied pharmacology.

[2]  C. Tseng.  Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. , 2008, Atherosclerosis.

[3]  D. Nebert,et al.  The vascular system as a target of metal toxicity. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Shih-Chieh Chen,et al.  Vascular leakage induced by exposure to arsenic via increased production of NO, hydroxyl radical and peroxynitrite. , 2008, Microvascular research.

[5]  A. Barchowsky,et al.  Positive signaling interactions between arsenic and ethanol for angiogenic gene induction in human microvascular endothelial cells. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Tajpreet Kaur,et al.  Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions. , 2008, Toxicology.

[7]  Y. Cha,et al.  Role of heme oxygenase-1 in vascular disease. , 2008, Current pharmaceutical design.

[8]  L. Grove,et al.  Angiogenic Potential of 3-Nitro-4-Hydroxy Benzene Arsonic Acid (Roxarsone) , 2008, Environmental health perspectives.

[9]  A. Agarwal,et al.  Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. , 2008, Circulation.

[10]  Y. Hsueh,et al.  A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. , 2007, Toxicology and applied pharmacology.

[11]  M. Kibriya,et al.  Association between Arsenic Exposure from Drinking Water and Plasma Levels of Soluble Cell Adhesion Molecules , 2007, Environmental health perspectives.

[12]  Huai-chih Chiang,et al.  Glutathione regulation of redox-sensitive signals in tumor necrosis factor-alpha-induced vascular endothelial dysfunction. , 2007, Toxicology and applied pharmacology.

[13]  Zhigang Zhou,et al.  TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. , 2007, Cellular signalling.

[14]  Ping Yang,et al.  Biphasic effect of arsenite on cell proliferation and apoptosis is associated with the activation of JNK and ERK1/2 in human embryo lung fibroblast cells. , 2007, Toxicology and applied pharmacology.

[15]  Tapan K. Mukherjee,et al.  High Concentration of Antioxidants N-Acetylcysteine and Mitoquinone-Q Induces Intercellular Adhesion Molecule 1 and Oxidative Stress by Increasing Intracellular Glutathione1 , 2007, The Journal of Immunology.

[16]  S. Lim,et al.  Blockade of Cytokine-Induced Endothelial Cell Adhesion Molecule Expression by Licorice Isoliquiritigenin Through NF-κB Signal Disruption , 2007, Experimental biology and medicine.

[17]  L. Hudson,et al.  Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. , 2007, Toxicology and applied pharmacology.

[18]  D. Stolz,et al.  Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver , 2007, Hepatology.

[19]  R. Stocker,et al.  Heme oxygenase-1: a novel drug target for atherosclerotic diseases? , 2006, Circulation.

[20]  Young-Myeong Kim,et al.  3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells. , 2006, Atherosclerosis.

[21]  B. Rovin,et al.  Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. , 2006, American journal of physiology. Heart and circulatory physiology.

[22]  H. Schröder,et al.  Heme oxygenase-1 and cardiovascular disease. , 2006, Histology and histopathology.

[23]  Jawed Alam,et al.  Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.

[24]  J. K. Kundu,et al.  Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. , 2005, Antioxidants & redox signaling.

[25]  M. Maines,et al.  30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. , 2005, Biochemical and biophysical research communications.

[26]  A. Sharrett,et al.  Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. , 2005, American journal of epidemiology.

[27]  Louis W. Chang,et al.  Arsenite enhances tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 , 2005 .

[28]  C. Klein,et al.  Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? , 2005, Toxicology and applied pharmacology.

[29]  T. Morita.  Heme Oxygenase and Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[30]  M. Webber,et al.  Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. , 2005, Toxicology and applied pharmacology.

[31]  R. Rice,et al.  Human epidermal cell protein responses to arsenite treatment in culture. , 2005, Chemico-biological interactions.

[32]  Te-Chang Lee,et al.  Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  D. Brooks,et al.  Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. , 2004, Toxicology and applied pharmacology.

[34]  M. Wei,et al.  Effects of co-administration of antioxidants and arsenicals on the rat urinary bladder epithelium. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  Jie Liu,et al.  Biokinetics and Subchronic Toxic Effects of Oral Arsenite, Arsenate, Monomethylarsonic Acid, and Dimethylarsinic Acid in v-Ha-ras Transgenic (Tg.AC) Mice , 2004, Environmental health perspectives.

[36]  S. Sassa,et al.  Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. , 2004, Current medicinal chemistry.

[37]  F. Bach,et al.  Heme Oxygenase-1 Modulates the Expression of Adhesion Molecules Associated with Endothelial Cell Activation1 , 2004, The Journal of Immunology.

[38]  Louis W. Chang,et al.  Vascular permeability alterations induced by arsenic , 2004, Human & experimental toxicology.

[39]  M. Luster,et al.  Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. , 2003, Environmental health perspectives.

[40]  F. Bach,et al.  Heme oxygenase-1: unleashing the protective properties of heme. , 2003, Trends in immunology.

[41]  A. Andrew,et al.  Genomic and proteomic profiling of responses to toxic metals in human lung cells. , 2003, Environmental health perspectives.

[42]  A. J. Gandolfi,et al.  Low-level arsenite induced gene expression in HEK293 cells. , 2003, Toxicology.

[43]  J. Gregg,et al.  Global alteration of gene expression in human keratinocytes by inorganic arsenic. , 2003, Carcinogenesis.

[44]  Louis W. Chang,et al.  Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. , 2003, Chemical research in toxicology.

[45]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[46]  H. Beall,et al.  Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. , 2002, Toxicology and applied pharmacology.

[47]  K. Jan,et al.  Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. , 2002, Environmental health perspectives.

[48]  A. Choi,et al.  Heme oxygenase-1: the "emerging molecule" has arrived. , 2002, American journal of respiratory cell and molecular biology.

[49]  Jie Liu,et al.  Stress-related gene expression in mice treated with inorganic arsenicals. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[51]  B. Yard,et al.  Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. , 2000, Kidney international.

[52]  M. Luster,et al.  Arsenic and atherosclerosis. , 2000, Toxicology and applied pharmacology.

[53]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[54]  D. R. Lewis,et al.  Drinking water arsenic in Utah: A cohort mortality study. , 1999, Environmental health perspectives.

[55]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[56]  U. Ikeda,et al.  Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. , 1996, Cardiovascular research.

[57]  Alan C. Nye,et al.  Investigation of arsenic exposure from soil at a superfund site. , 1995, Environmental research.

[58]  A H Smith,et al.  Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. , 1994, Archives of environmental health.

[59]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[60]  T E McKone,et al.  Estimating human exposure through multiple pathways from air, water, and soil. , 1991, Regulatory toxicology and pharmacology : RTP.

[61]  P Edelman,et al.  Environmental and workplace contamination in the semiconductor industry: implications for future health of the workforce and community. , 1990, Environmental health perspectives.

[62]  E. Reyes,et al.  Dehydroepiandrosterone inhibits the TNF-alpha-induced inflammatory response in human umbilical vein endothelial cells. , 2007, Atherosclerosis.

[63]  S. Ryter,et al.  Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. , 2005, Antioxidants & redox signaling.

[64]  Jen-kun Lin,et al.  Arsenite stimulates cyclooxygenase‐2 expression through activating IκB kinase and nuclear factor κB in primary and ECV304 endothelial cells , 2002 .

[65]  K. Jan,et al.  DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. , 2000, Free radical biology & medicine.

[66]  A. Smith,et al.  Vascular effects of chronic arsenic exposure: a review. , 1994, Epidemiologic reviews.